Analgesics in Australia - Product Image

Analgesics in Australia

  • ID: 228392
  • Report
  • Region: Australasia, Australia
  • 20 Pages
  • Euromonitor International
1 of 4
The ban on OTC sales of codeine will be the biggest factor impacting growth in analgesics over the forecast period, with the ban due to come into effect from February 2018. In December 2016, Australia’s drug regulator, the Therapeutic Goods Administration (TGA), shifted painkillers containing codeine from schedule two or schedule three to schedule starting from February 2018, due to concerns about the addictive nature of codeine.

The Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
ANALGESICS IN AUSTRALIA

List of Contents and Tables:
  • Headlines
  • Prospects
  • the Ban on OTC Codeine
  • the Impact of the Ban on Adult Combination Products - Analgesics
  • Manufacturers Innovate To Offset Potential Losses
  • Competitive Landscape
  • Multinationals Dominate
  • Strong Competition From Generics Sees Panadol Lose Share
  • Fast-acting Formulae and Convenience Are Demanded by Consumers
  • Category Data
  • Table 1 Sales of Analgesics by Category: Value 2012-2017
  • Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  • Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  • Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  • Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  • Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
  • Executive Summary
  • Consumer Health Delivers Modest Growth
  • Crackdown on OTC Codeine
  • Mergers and Acquisitions Are Commonplace in Consumer Health
  • Discount Pharmacies Continue To See An Increasing Share
  • Amazon's Entrance Set To Shake-up the Market
  • Market Indicators
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 9 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 10 Sales of Consumer Health by Category: Value 2012-2017
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  • Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Summary 1 OTC: Switches 2016-2017
  • Definitions
  • Sources
  • Summary 2 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll